Hypertensive Krise und posteriores reversibles
                    Enzephalopathie-Syndrom (PRES)

Olaf Eberhardt

doi:10.1055/s-0043-122600

Fortschritte der Neurologie · Psychiatrie, Table of Contents

Fortschr Neurol Psychiatr 2018; 86(05): 290-300
DOI: 10.1055/s-0043-122600

Übersicht

Georg Thieme Verlag KG Stuttgart · New York

Hypertensive Krise und posteriores reversibles Enzephalopathie-Syndrom (PRES)

Hypertensive crisis and posterior reversible encephalopathy syndrome (PRES)

Olaf Eberhardt

Klinikum Bogenhausen Klinik für Neurologie

› Author Affiliations

Abstract

Zusammenfassung

Die therapeutische Dringlichkeit der hypertensiven Entgleisung wird vorrangig vom Vorliegen von akuten neurologischen, okulären, kardiopulmonalen oder renalen Endorganschäden bestimmt. Ohne akute Endorganschäden (hypertensive urgency) ist in der Regel eine orale Behandlung mit dem Ziel der RR-Normalisierung über 24–48 h ausreichend. Bei gravierenden hypertensiven Organsymptomen (hypertensive emergency, hypertensiver Notfall) ist eine zügige intravenöse Initialtherapie erforderlich, bei der die Präparatewahl und das Blutdruckziel von der Organmanifestation und Begleiterkrankungen abhängig sind. Empfehlungen zur optimalen Blutdrucksteuerung bei akuten neurovaskulären Erkrankungen werden durch divergierende Studienergebnisse und die Vielfalt potentiell relevanter Parameter erschwert. Das breite Spektrum des posterioren reversiblen Enzephalopathie-Syndroms kann in atypischen Fällen die Diagnose erschweren. Clevidipin könnte in Zukunft eine willkommene Erweiterung der intravenösen Therapieoptionen auch für neurologische Patienten darstellen.

Abstract

The urgency and intensity of therapeutic response to a hypertensive crisis are governed by the presence or absence of acute end-organ damage, which define hypertensive emergency and hypertensive urgency, respectively. In case of hypertensive urgency a slow and moderate lowering of blood pressure by oral antihypertensive agents seems adequate, while the approach to hypertensive emergency has to be tailored to the specific type of organ failure. Optimal blood pressure management in the context of neurovascular emergencies is made difficult by contradictory data from observational and interventional studies. It might prove advantageous to individualize treatment according to characteristics such as the location of persistent vessel occlusion or the presence of collaterals. Reversible posterior encephalopathy may present with atypical features that might make diagnosis difficult. Clevidipine might be a welcome supplement to current intravenous antihypertensive agents in neurological disease.

Schlüsselwörter

Hypertonie - hypertensive Krise - Schlaganfall - Enzephalopathie - PRES

Key words

hypertension - hypertensive urgency - hypertensive emergency - stroke - encephalopathy - PRES

Full Text

References

Literatur
1 Shah M, Patil S, Patel B. et al. Trends in Hospitalization for Hypertensive Emergency, and Relationship of End-Organ Damage With In-Hospital Mortality. Am J Hypertens 2017; 30: 700-706
2 Weber MA, Schiffrin EL, White WB. Clinical Practice Guidelines for the Management of Hypertension in the Community. A Statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens 2014; 16: 14-26
3 Varounis C, Katsi V, Nihoyannopoulos P. et al. Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature. Front Cardiovasc Med 2017; 3: 51
4 Liman T, Siebert E, Endres M. Kopfschmerz und Bluthochdruck. Nervenarzt 2010; 81: 963-72
5 Al Bannay R, Böhm M, Husain A. Heart rate differentiates urgency and emergency in hypertensive crisis. Clin Res Cardiol 2013; 102: 593-8
6 Vilela-Martin JF1. Vaz-de-Melo RO, Kuniyoshi CH. et al. Hypertensive crisis: clinical-epidemiological profile. Hypertens Res 2011; 34: 367-71
7 Pinna G, Pascale C, Fornengo P. et al. Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study. PLoS One 2014; 9: e93542
8 Park SK, Lee DY, Kim WJ. et al. Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial. J Hypertens 2017; 35: 1474-1480
9 den Hertog HM, van der Worp HB, van Gemert HM. Effects of high-dose paracetamol on blood pressure in acute stroke. Acta Neurol Scand 2012; 125: 265-71
10 Henny-Fullin K, Buess D, Handschin A. et al. Hypertensive Krise. Ther Umsch 2015; 72: 405-11
11 Ipek E1. Oktay AA, Krim SR. Hypertensive crisis: an update on clinical approach and management. Curr Opin Cardiol 2017; 32: 397-406
12 Bönner G. Der hypertensive Notfall. Dtsch Med Wochenschr 2017; 142: 1437-1445
13 Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-219
14 Tzeng YC1. Ainslie PN. Blood pressure regulation IX: cerebral autoregulation under blood pressure challenges. Eur J Appl Physiol 2014; 114 (03) 545-59
15 Rivera-Lara L, Zorrilla-Vaca A, Geocadin RG. et al. Cerebral Autoregulation-oriented Therapy at the Bedside: A Comprehensive Review. Anesthesiology 2017; 126: 1187-1199
16 Bor-Seng-Shu E, Kita WS, Figueiredo EG. et al. Cerebral hemodynamics: concepts of clinical importance. Arq Neuropsiquiatr 2012; 70: 352-6
17 Aries MJ, Elting JW, De Keyser J. et al. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke 2010; 41: 2697-704
18 Xiong L, Liu X, Shang T. et al. Impaired cerebral autoregulation: measurement and application to stroke. J Neurol Neurosurg Psychiatry 2017; 88: 520-531
19 Webb AJ, Rothwell PM. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke 2011; 42: 2860-5
20 Liu CH, Wei YC, Lin JR. Initial blood pressure is associated with stroke severity and is predictive of admission cost and one-year outcome in different stroke subtypes: a SRICHS registry study. BMC Neurol 2016; 16: 27
21 Ishitsuka K, Kamouchi M, Hata J. et al. High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry. Hypertension 2014; 63: 54-60
22 Jayarajah U, Gunasekera SN, Seneviratne SL. Management of hypertensive crisis in acute neurovascular emergencies. Ann Clin Exp Hypertension 2017; 5: 1048
23 Regenhardt RW, Das AS, Stapleton CJ. et al. Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion. Front Neurol 2017; 8: 317 doi: 10.3389/fneur.2017.00317
24 Bath PM, Krishnan K. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2014; 10: CD000039
25 Altinbas A, Algra A, Brown MM. et al. Effects of carotid endarterectomy or stenting on blood pressure in the International Carotid Stenting Study (ICSS). Stroke 2011; 42: 3491-6
26 Li C, Wang Y, Chen Y. et al. Optimal blood pressure levels in patients undergoing intravenous thrombolysis for AIS. Minerva Med 2015; 106: 255-258
27 Gill D, Cox T, Aravind A. et al. A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery. J Stroke Cerebrovasc Dis 2016; 25: 1539-43
28 McManus M, Liebeskind DS . Blood Pressure in Acute Ischemic Stroke. J Clin Neurol 2016; 12: 137-46
29 Fischer U, Mattle HP. Blood Pressure in Acute Stroke: Still No Answer for Management. Stroke 2017; 48: 1717-1719
30 Mulder MJHL, Ergezen S, Lingsma HF. et al. Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands). Stroke 2017; 48: 1869-1876
31 Goyal N, Tsivgoulis G, Pandhi A. et al. Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes. Neurology 2017; 8 (89) 540-547
32 Kellert L, Hametner C, Ahmed N. et al. Reciprocal Interaction of 24-Hour Blood Pressure Variability and Systolic Blood Pressure on Outcome in Stroke Thrombolysis. Stroke 2017; 48: 1827-1834
33 Fischer U, Cooney MT, Bull LM. et al. Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. Lancet Neurol 2014; 13: 374-84
34 Li W, Jin C, Vaidya A. et al. Blood Pressure Trajectories and the Risk of Intracerebral Hemorrhage and Cerebral Infarction: A Prospective Study. Hypertension 2017; 70: 508-514
35 Balci K, Utku U, Asil T. et al. The effect of admission blood pressure on the prognosis of patients with intracerebral hemorrhage that occurred during treatment with aspirin, warfarin, or no drugs. Clin Exp Hypertens 2012; 34: 118-24
36 Rodriguez-Luna D, Piñeiro S, Rubiera M. et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol 2013; 20: 1277-83
37 Sakamoto Y, Koga M, Yamagami H. et al. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke 2013; 44: 1846-51
38 Mohammad Y, Qureshi A. Blood Pressure Management in Intracerebral Hemorrhage. Semin Neurol 2016; 36: 269-73
39 Kuramatsu JB, Gerner ST, Schellinger PD. et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 2015; 313: 824-36
40 Anderson CS, Heeley E, Huang Y. et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368: 2355-65
41 Carcel C, Wang X, Sato S. et al. Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results. Stroke 2016; 47: 1651-3
42 Koga M, Arihiro S, Hasegawa Y. Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study. J Stroke Cerebrovasc Dis 2014; 23: 2780-7
43 Qureshi AI, Palesch YY, Suarez JI. Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. N Engl J Med 2016; 375: e48
44 Lattanzi S, Cagnetti C, Provinciali L. et al. How Should We Lower Blood Pressure after Cerebral Hemorrhage? A Systematic Review and Meta-Analysis. Cerebrovasc Dis 2017; 43: 207-213
45 Anderson CS, Selim MH, Molina CA. et al. Intensive Blood Pressure Lowering in Intracerebral Hemorrhage. Stroke 2017; 48: 2034-2037
46 Morotti A, Boulouis G, Romero JM. et al. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion. Neurology 2017; 89: 548-554
47 Morotti A, Brouwers HB, Romero JM. et al. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial. JAMA Neurol 2017; 74: 950-960
48 Fontana J, Scharf J, Weiß C. et al. The spontaneous arterial blood pressure rise after aneurysmal subarachnoid hemorrhage – a biphasic phenomenon. Clin Neurol Neurosurg 2015; 137: 22-7
49 Manning L, Robinson TG, Anderson CS . Control of blood pressure in hypertensive neurological emergencies. Curr Hypertens Rep 2014; 16: 436
50 Sutter R, Kaplan PW. What to see when you are looking at confusion: a review of the neuroimaging of acute encephalopathy. J Neurol Neurosurg Psychiatry 2015; 86: 446-59
51 Gao B, Lyu C, Lerner A. et al. Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?. J Neurol Neurosurg Psychiatry 2017; Aug 9 pii: jnnp-2017-316225 doi: 10.1136/jnnp-2017–316225. [Epub ahead of print]
52 della Faille L, Fieuws S, van Paesschen W. Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome. Acta Neurol Belg 2017; 117: 469-475
53 Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol 2017; 264: 1608-1616
54 Yamamoto H, Natsume J, Kidokoro H. Clinical and neuroimaging findings in children with posterior reversible encephalopathy syndrome. Eur J Paediatr Neurol 2015; 19: 672-8
55 Siebert E, Bohner G, Endres M. et al. Clinical and radiological spectrum of posterior reversible encephalopathy syndrome: does age make a difference? A retrospective comparison between adult and pediatric patients. PLoS One 2014; 9: e115073
56 Rykken JB, McKinney AM. Posterior reversible encephalopathy syndrome. Semin Ultrasound CT MR 2014; 35: 118-35
57 Shintani S, Hino T, Ishihara S. et al. Reversible brainstem hypertensive encephalopathy (RBHE): Clinicoradiologic dissociation. Clin Neurol Neurosurg 2008; 110: 1047-53
58 Siebert E, Bohner G, Liebig T. et al. Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study. J Neurol 2017; 264: 237-242
59 Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14: 914-25
60 Heo K, Cho KH, Lee MK. et al. Development of epilepsy after posterior reversible encephalopathy syndrome. Seizure 2016; 34: 90-4
61 Guiga H, Decroux C, Michelet P. et al. Hospital and out-of hospital mortality in 670 hypertensive emergencies and urgencies. J Clin Hypertens 2017; 19: 1137-42